HCV replication in PBMC and its influence on interferon therapy

World Journal of Gastroenterology

Volumn 9, Issue 2, 2003, Pages 291-294

  Gong, Guo Zhong ^a   Lai, Li Ying ^a   Jiang, Yong Fang ^a   He, Yan ^a   Su, Xian Shi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; INTERFERON; PRIMER RNA; VIRUS PROTEIN; VIRUS RNA;

ACUTE HEPATITIS; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS DETECTION; VIRUS REPLICATION;

EID: 0037442153     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i2.291     Document Type: Article

References (36)

1. Wang Y, Okamoto H, Mishiro S. HCV genotypes in China. Lancet 1992; 339: 1168
2. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, Nikolopoulou GB, Vargas H, Rakela J. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol 2002; 76: 10064-10068
3. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrect JK. Interferon alfa2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998; 339: 1485-1492
4. Poynard T, Marcellin P, Lee SS, Minuk K, Ideo G, Bain V, Heathcote J, Zeuzem S, Trepo C, Albrecht J. Randomised trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon a2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998; 352: 1426-1432
5. Feray C, Gigou M, Samuel D, Parasis J, Wilber J, David MF, Urdea MS, Reynes M, Brechot C, Bismuth H. The course of hepatitis C after liver transplantation. Hepatology 1994: 20: 1137-1143
6. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation 1998; 5: 664-666
7. Schmidt MN, Wu P, Brashear D, KlinzmaN D, Philips MJ, LaBrecque DR, Stapleton JT. Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells. Hepatology 1998; 28: 1110-1116
8. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues. Hepatology 1998; 28: 1398-1401.
9. Cheng JL, Liu BL, Zhang Y, Tong WB, Yan Z, Feng BF. Hepatitis C virus in human B lymphocytes transformed by Epstein-Barr virus in vitro by in situ reverse transcriptase-polymerase chain reaction. World J Gastroenterol 2001; 3: 370-375
10. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Maymi M. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infections sources. J Gen Virol 1992; 73: 673-678
11. Chen LB, Chen PL, Fan GR, Li L, Liu CY. Localization of hepatitis C virus core protein in the nucleus of PBMCs of hepatitis C patients. Zhonghua Shiyan He Linchuangbin Duxue Zazhi 2002; 16: 37-39
12. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS. Detection of replication form of HCVRNA in peripheral blood mononuclear cells. J Infect Dis 1992; 166: 1167-1169
13. Taliani G, Badolato MC, Lecce R, Poliandri G, Bozza A, Duca F, Pasquazzi C, Clementi C, Furlan C, Bac CD. HCV RNA in PBMC: Relation with response to IFN treatment. J Med Virol 1995; 47: 16-22
14. Zignego AL, Carli MD, Monti M, Careccia G, Villa GL, Giannini C, D'Elios MM, Prete GD, Gentilini P. HCV infection of mononuclear cells from peripheral blood and liver infiltrates in chronically infected patients. J Med Virol 1995; 47: 58-64
15. Cribier B, Schmitt C, Bingen A, Kirn A, Keller F. In vitro infection of peripheral blood mononuclear cells by HCV. J of Gen Virol 1995; 76: 2485-2491
16. Chang TT, Yong KC, Yang YJ, Lei HY, Wu HL. Hepatitis C virus RNA in PBMC: Comparing acute and chronic hepatitis C virus infection. Hepatology 1996; 23: 977-981
17. Müller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Thielmann L. Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 1993; 74: 669-676
18. Mihm S, Hartmann H, Ramadori G. A reevaluation of the association of hepatitis C virus replicative intermediates with peripheral blood cells including granulocytes by a tagged reverse transcriptase/polymerase chain reaction technique. J Hepatol 1996; 24: 491-497
19. Lerat H, Berby F, Trabaud MA, Vidalin O, Major M, Trepo C, Inchauspe G. Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. J Clin Invest 1996; 97: 845-851
20. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other Flaviridae viruses enter cells via low density lipoprotein receptor. PNAS 1999; 96: 12766-12771
21. Meier V, Mihm S, Wietzke-Braun P, Ramadori G. HCV-RNA positivity in peripheral blood mononuclear cells of patients with chronic HCV infection: Does it really mean viral replication. World J Gastroenterol 2001; 2: 228-232
22. Sansonno D, Lacobelli AR, Cornacchiulo V, Iodice G, Dammacco F. Detection of HCV proteins by immunofluorescence and HCVRNA genomic sequences by non-isotopic in situ hybridization in bone marrow cells and PBMC of chronically HCV infected patients. Clin Exp Immunol 1996; 103: 414-421
23. Da Silva LC, Bassit L, Ono-Nita SK, Pinho JR, Nishiya A, Madruga CL, Carriilho. High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: A pilot study. J Gastroenterol 2002; 37: 732-736
24. Omata M, Yokosuka O, Takano S, Kato N, Hosoda K, Imazeki F, Tada M, Ito Y, Ohto M. Resolution of acute hepatitis C after therapy with natural beta interferon. Lancet 1991; 338: 914-915
25. Löhr HF, Goergen B, Heyer KH. HCV replication in mononuclear cells stimulates anti-HCV secreting B cells and reflects non-responsiveness to interferon-alpha. J Med Virol 1995; 46: 314-320
26. Saleh MG, Tibbs CJ, Koskinas J, Pereira LMMB, Bomford AB, Portmann BC, Mcfarlane IG, Williams R. Hepatic and extrahepatic HCV replication in relation to response to interferon therapy. Hepatology 1994; 20: 1399-1404
27. Manesis EK, Papaioannou C, Gioustozi A, Kafiri G, Koskinas J, Hadziyannis SJ. Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alpha-2b for 6 or 12 months: A 4 year follow-up of 211 patients. Hepatology 1997; 26: 734-739
28. Torres B, Martin JL, Caballero A, Villalobos M, Olea N. HCV in serum, peripheral blood mononuclear cells and lymphocyte subpopulations in C-hepatitis patients. Hepatol Res 2000; 18: 141-151
29. Knolle PA, Kremp S, Hohler T, Krummenauer F, Schirmacher P, Gerken G. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. J Viral Hepat 1998; 5: 399-406
30. Hino K, Yamaguchi Y, Fujiwara D, Katoh Y, Korenaga M, Okazaki M, Okuda M, Okita K. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: A prospective study. J Viral Hepat 2000; 7: 36-42
31. Antonelli G, Simeoni E, Turrizian O, Tesoro R, Redaelli A, Roffi L, Antonelli L, Pistello M, Dianzani F. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy. J Interferon Cytokine Res 1999; 19: 243-251
32. Schiappa DA, Mittal C, Brown JA, Mika SP. Relationship of hepatitis C genotype 1 NS5A sequence mutations to early phase viral kinetics and interferon effectiveness. J Infect Dis 2002; 185: 868-877
33. Farci P, Strazzera R, Alter HJ, Farci S, Degioannis D, Coiana A, Peddis G, Usai F, Serra G, Chessa L, Diaz G, Balestrieri A, Purcell RH. Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome. Proc Natl Acad Sci U S A 2002; 99: 3081-3086
34. Jiang J, Zhang L, Gigou M. Compartmental distribution of hepatitis C virus quasispecies in mononuclear cells and liver. Zhonghua Yixue Zazhi 1998; 78: 265-268
35. Maggi F, Fornai C, Morrica A, Vatteroni MI, Giorgi M, Marchi S, Ciccorossi P, Bendinelli M, Pistello M. Divergent evolution of hepatitis C virus in liver and peripheral blood mononuclear cells of infected patients. J Med Virol 1999; 57: 57-63
36. Kessler HH, Pierer K, Santner BI, Vellimedu UK, Stelzl E, Marth E, Fickert P, Stauber RE. Evaluation of molecular parameters for routine assessment of viremia in patients with chronic hepatitis C who are undergoing antiviral therapy. J Hum Virol 1998; 1: 341-349